Skip to main content

Hold the painkillers (hindu,)

They may overtax kidneys and reduce muscles’ ability to recover, say studies

Taking ibuprofen and related over-the-counter painkillers could have unintended and worrisome consequences for people who vigorously exercise. These popular medicines, known as non-steroidal anti-inflammatory drugs, or NSAIDs, work by suppressing inflammation. But according to two new studies, in the process they potentially may also overtax the kidneys during prolonged exercise and reduce muscles’ ability to recover afterward.

Anyone who spends time around people who exercise knows that painkiller use is common among them. Some athletes joke about taking “vitamin I,” or ibuprofen, to blunt the pain of strenuous training and competitions. Others rely on naproxen or other NSAIDs to make hard exercise more tolerable.

NSAID use is especially widespread among athletes in strenuous endurance sports like marathon and ultramarathon running.

But in recent years, there have been hints that NSAIDs might not have the effects in athletes that they anticipate.Some studies have found that those who take the painkillers experience just as much muscle soreness as those who do not. A few case studies also have suggested that NSAIDs might contribute to kidney problems in endurance athletes, and it was this possibility that caught the attention of Dr. Grant S. Lipman, a clinical associate professor of medicine at Stanford University and the medical director for several ultramarathons.

How they work


NSAIDs work, in part, by blunting the body’s production of a particular group of biochemicals, called prostaglandins, that otherwise flood the site of injuries in the body. There, they jump-start processes contributing to pain and inflammation. Prostaglandins also prompt blood vessels to dilate, or widen, increasing blood flow to the affected area.

Taking NSAIDs results in fewer prostaglandins and consequently less inflammation and less dilation of blood vessels. Whether these effects are advisable in people exercising for hours has been uncertain, however.

Study results


So for one of the new studies, published on July 5 in the Emergency Medical Journal, Dr. Lipman asked 89 participants in several multi-day ultramarathons around the world to swallow either an ibuprofen pill or a placebo every four hours during a 50-mile stage of their race.

Afterwards, he and his colleagues drew blood from the racers and checked their levels of creatinine, a byproduct of the kidneys’ blood filtering process. High levels of creatinine in an otherwise healthy person are considered to be a sign of acute kidney injury.

The researchers found that many of the ultra runners, about 44%, had creatinine levels high enough to indicate acute kidney injury after running 50 miles.

But the incidence was particularly high among the runners who had taken ibuprofen. They were about 18% more likely to have developed an acute kidney injury than the racers swallowing a placebo. Furthermore, their injuries, based on creatinine levels, tended to be more severe.

The study did not follow the racers in subsequent days or weeks, but Dr. Lipman believes that they all recovered normal kidney function soon after the event ended. The experiment also was not designed to determine why ibuprofen might have increased the risk for kidney problems in the racers. But Dr. Lipman and his colleagues suspect that, by inhibiting prostaglandins, the drug prevented blood vessels from widening as they otherwise might have. Slightly strangling blood flow to the kidneys, he says, might make it harder for those organs to filter the blood.

The second study, published in May in the Proceedings of the National Academy of Sciences, raised similar concerns. It found that by reducing the production of prostaglandins, NSAIDs change how a body responds to exertion, this time deep within the muscles. For that study, researchers in the department of microbiology at Stanford University looked first at muscle cells and tissue from mice that had experienced slight muscular injuries, comparable to those we might develop during strenuous exercise. The tissue soon filled with a particular type of prostaglandin that turned out to have an important role: It stimulated stem cells within the muscles to start multiplying, creating new muscle cells that then repaired the tissue damage. Afterwards, tests showed that the healed muscle tissue was stronger than it had been before.

This microscopic process mimics what should happen when we exercise strenuously, straining and then rebuilding our muscles.

But when the researchers used NSAIDs to block the production of prostaglandins within the muscles, they noted that fewer stem cells became active, fewer new cells were produced, and the muscle tissue, even after healing, was not as strong and springy as in tissues that had not been exposed to the drug. They saw the same reaction both in isolated muscle cells in petri dishes and in living mice treated with NSAIDs.

We are not mice, of course. But the findings imply that in people, too, anti-inflammatory painkillers might slightly impair muscles’ ability to regenerate and strengthen after hard workouts, says Helen Blau, the director of the Baxter Laboratory for Stem Cell Biology at Stanford, who oversaw the experiment. “There’s a reason for the inflammation” in the body after exercise, she says. “It’s part of the regenerative process and not a bad thing.” In fact, at the cellular level, she says, “it does look as if no pain means no gain.” She suggests that those of us who exercise might want to consider options others than NSAIDs to relieve the aches associated with working out and competing.

Dr. Lipman, who is a clinician as well as a distance runner, agrees. “Maybe consider acetaminophen,” he says, a painkiller found in Tylenol that does not affect inflammation. Or skip the drugs altogether. “I often tell people, think ice baths,” he says. NYT

Comments

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i